Jeff Yass’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,236,697
| Closed | -$141K | – | 10464 |
|
|
2018
Q4 | $141K | Sell |
1,236,697
-938,999
| -43% | -$616K | ﹤0.01% | 8032 |
|
|
2018
Q3 | $3.7M | Sell |
2,175,696
-253,974
| -10% | -$455K | ﹤0.01% | 3074 |
|
|
2018
Q2 | $4.23M | Buy |
2,429,670
+506,295
| +26% | +$875K | ﹤0.01% | 2931 |
|
|
2018
Q1 | $3.52M | Sell |
1,923,375
-12,388,785
| -87% | -$26.2M | ﹤0.01% | 3005 |
|
|
2017
Q4 | $31.9M | Buy |
14,312,160
+11,782,938
| +466% | +$29.3M | 0.01% | 936 |
|
|
2017
Q3 | $7.33M | Buy |
2,529,222
+133,512
| +6% | +$455K | ﹤0.01% | 2074 |
|
|
2017
Q2 | $10.7M | Sell |
2,395,710
-1,001,984
| -29% | -$4.13M | ﹤0.01% | 1648 |
|
|
2017
Q1 | $15.8M | Buy |
3,397,694
+2,278,872
| +204% | +$13.2M | 0.01% | 1253 |
|
|
2016
Q4 | $6.81M | Buy |
1,118,822
+766,468
| +218% | +$4.01M | ﹤0.01% | 1998 |
|
|
2016
Q3 | $1.94M | Sell |
352,354
-116,794
| -25% | -$547K | ﹤0.01% | 3621 |
|
|
2016
Q2 | $1.78M | Buy |
469,148
+256,110
| +120% | +$868K | ﹤0.01% | 3773 |
|
|
2016
Q1 | $588K | Sell |
213,038
-31,383
| -13% | -$114K | ﹤0.01% | 6113 |
|
|
2015
Q4 | $1.39M | Buy |
244,421
+372
| +0.2% | +$2.27K | ﹤0.01% | 4754 |
|
|
2015
Q3 | $1.29M | Buy |
244,049
+223,910
| +1,112% | +$1.73M | ﹤0.01% | 5153 |
|
|
2015
Q2 | $167K | Sell |
20,139
-219,899
| -92% | -$1.07M | ﹤0.01% | 9429 |
|
|
2015
Q1 | $1.11M | Buy |
240,038
+107,104
| +81% | +$348K | ﹤0.01% | 5552 |
|
|
2014
Q4 | $405K | Sell |
132,934
-145,788
| -52% | -$431K | ﹤0.01% | 7627 |
|
|
2014
Q3 | $776K | Buy |
278,722
+5,349
| +2% | +$19.4K | ﹤0.01% | 6420 |
|
|
2014
Q2 | $1.11M | Buy |
273,373
+50,794
| +23% | +$216K | ﹤0.01% | 5822 |
|
|
2014
Q1 | $1.18M | Buy |
222,579
+153,671
| +223% | +$861K | ﹤0.01% | 5216 |
|
|
2013
Q4 | $382K | Buy |
68,908
+41,169
| +148% | +$178K | ﹤0.01% | 7185 |
|
|
2013
Q3 | $125K | Sell |
27,739
-63,439
| -70% | -$284K | ﹤0.01% | 8000 |
|
|
2013
Q2 | $388K | Buy |
+91,178
| New | +$458K | ﹤0.01% | 6410 |
|
Other funds holding SGYP
Jeff Yass's SGYP Position: Q1 2019 in Review
Jeff Yass sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 1,236,697 shares — an estimated $141K sold.
Jeff Yass first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $31.9M in Q4 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Jeff Yass reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Jeff Yass sold 1,236,697 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $141K.
- Jeff Yass first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Jeff Yass's Synergy Pharmaceuticals, Inc Common Stock position peaked at $31.9M in Q4 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.